-
Breaking the "Untreatable": Biostar Pharma's UTD1 Achieves First Patient Dosing in U.S. for Pivotal Clinical Trial for Breast Cancer Brain Metastases
16 Dec 2025 10:23 GMT
… the treatment of breast cancer brain metastases.
Approximately 20-50% of advanced … breast cancer patients develop brain metastases [3]. Due to the presence … -clinical-trial-for-breast-cancer-brain-metastases-302643017.html
SOURCE Biostar Pharma …
-
Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases
15 Dec 2025 12:00 GMT
… brain metastases. Images confirm metabolic activity in brain metastases … participants with suspected recurrent brain metastases. Secondary endpoints are … radiosurgery (SRS)-treated brain metastases.
² A hybrid [ … , breast, and brain metastases. Learn more at …
-
BeyondSpring Announces New Analyses of DUBLIN-3 Phase 3 Study Showing Survival Benefit of Plinabulin + Docetaxel in Post Anti-PD-(L)1 for Non-squamous EGFR WT NSCLC and a Reduction in Brain Metastasis Compared to Docetaxel at NACLC 2025
11 Dec 2025 12:00 GMT
… .
Reduction in new brain metastasis: The incidence of new brain metastasis was reduced to … Meeting. The observed reductions in brain metastasis and the substantial improvement in …
-
Chemical Synthesis Peptide Drugs Market Set to Reach USD 4.82 Billion by 2034, Growing at a 6.54% CAGR Driven by Automation and Green Chemistry Advances
16 Dec 2025 15:00 GMT
… ). Whereas, PDCs, like SNG1005 (for brain metastases), are in Phase 3 and …
-
Recce wins ‘up to’ $85 million of R&D trial incentives
16 Dec 2025 03:13 GMT
… emission tomography agent for detecting brain metastases from other primary tumours.
RAD … 30 individuals with confirmed recurrent brain metastases from solid tumours of different …
-
<![CDATA[CNS Disease Considerations and Implications for Treatment Selection for BRAF V600E-Mutant Metastatic NSCLC ]]>
16 Dec 2025 01:40 GMT
… cancer management: patients with baseline brain metastases. Because BRAF-mutant lung cancer … CNS-tropic, the incidence of brain metastases is lower than in EGFR …
-
Tesla, iRobot, ServiceNow, Radiopharm Theranostics, Kyverna Therapeutics: Stocks Making The Biggest Moves Today
15 Dec 2025 22:43 GMT
… selective tumor uptake in the brain metastases.
RADX stock is up 166% …
-
Why Is Radiopharm Theranostics Stock Rallying Over 140%?
15 Dec 2025 17:07 GMT
… the diagnosis of suspected recurrent brain metastases from solid tumors of … assessed by PET imaging of brain metastases.
The results showed significant … uptake in the brain metastases. Images confirm metabolic activity in brain metastases compared to …
-
Biotechs get their clinical trial ducks in a row
15 Dec 2025 02:08 GMT
… uptake in suspected or recurrent brain metastases”.
Dubbed RAD-101, the … These patients have confirmed recurrent brain metastases, from solid tumours of different … US patients are diagnosed with brain metastases annually. Independent research appraises the …
-
<![CDATA[SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer]]>
13 Dec 2025 22:52 GMT
… analyses in patients with baseline brain metastases suggested a doubling of PFS … historically limited therapeutic options for brain metastases, which occur in up to … encouraging PFS in patients with brain metastases.
5. Safety and Dosing Considerations …
About
© 1995-2025